XBrane Affordable Pharmaceuticals for a Global Need

Xbrane in Brief
Biosimilars
Technology
Products
Career

Corporate Governance
Investors & Media
Contact
English
Svenska

Press Releases

Loading…

Contact Investor Relations

Martin Åmark, CEO/IR
+46 (0) 763-093 777
martin.amark@xbrane.com

The share
Financial Reports
Presentations
Press Releases
Financial Calendar
Photos
Media
Prospectus

Xbrane Biopharma AB
(publ) Main office
Telefon: +46 (0) 760 346 33
Email: info@xbrane.com
Adress: Xbrane Biopharma
Banvaktsvägen 22
171 48 Solna Sweden

About

Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars and long-acting injectables. Xbrane has world leading expertise in developing generics for long-acting injectable drugs and proprietary high-yield protein expression technology for the development of biosimilars.

Links

Xbrane in Brief
Biosimilars
Technology
Products
Career
Corporate Governance
Investors & Media
Contact
Data Protection

Social Media

Facebook
Twitter
LinkedIn